An Observational Study on Post-chronic Pancreatitis Diabetes Mellitus

NCT05764629 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 324

Last updated 2023-05-26

No results posted yet for this study

Summary

To explore the risk factors influencing glycemic status, optimized treatment, and prognosis of post-chronic pancreatitis diabetes mellitus (PPDM-C).

Conditions

Interventions

DIAGNOSTIC_TEST

blood test

Testing the peripheral blood for PPDM-C, including blood glucose, glycated hemoglobin A1c, fasting insulin and C-peptide, etc.

DRUG

pharmacologic approaches to glycemic treatment

documenting the change of glycemic treatment during the follow-up period

Sponsors & Collaborators

  • Changhai Hospital

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-01
Primary Completion
2024-02-29
Completion
2030-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05764629 on ClinicalTrials.gov